{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:56:17Z","timestamp":1789736177353,"version":"4.0.1"},"publisher-location":"Cham","reference-count":190,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030580032","type":"print"},{"value":"9783030580049","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/82_2018_103","type":"book-chapter","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T10:39:14Z","timestamp":1532515154000},"page":"129-163","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Targeting Glycans on Human Pathogens for Vaccine Design"],"prefix":"10.1007","author":[{"given":"Stefanie A.","family":"Krumm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie J.","family":"Doores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"issue":"2","key":"103_CR1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1469-0691.2003.00530.x","volume":"9","author":"G Ada","year":"2003","unstructured":"Ada G, Isaacs D (2003) Carbohydrate-protein conjugate vaccines. Clin Microbiol Infect 9(2):79\u201385","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"103_CR2","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1128\/JVI.01349-10","volume":"85","author":"C Agrawal-Gamse","year":"2011","unstructured":"Agrawal-Gamse C, Luallen RJ, Liu B, Fu H, Lee FH, Geng Y, Doms RW (2011) Yeast-elicited cross-reactive antibodies to HIV Env glycans efficiently neutralize virions expressing exclusively high-mannose N-linked glycans. J Virol 85(1):470\u2013480. https:\/\/doi.org\/10.1128\/JVI.01349-10","journal-title":"J Virol"},{"issue":"1","key":"103_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.virol.2010.03.021","volume":"402","author":"KB Alexandre","year":"2010","unstructured":"Alexandre KB, Gray ES, Lambson BE, Moore PL, Choge IA, Mlisana K, Karim SS, McMahon J, O\u2019Keefe B, Chikwamba R, Morris L (2010) Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin Cyanovirin-N and Scytovirin. Virology 402(1):187\u2013196. https:\/\/doi.org\/10.1016\/j.virol.2010.03.021","journal-title":"Virology"},{"issue":"4","key":"103_CR4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrd3012","volume":"9","author":"RD Astronomo","year":"2010","unstructured":"Astronomo RD, Burton DR (2010) Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat Rev Drug Discov 9(4):308\u2013324. https:\/\/doi.org\/10.1038\/nrd3012","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"103_CR5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.chembiol.2010.03.012","volume":"17","author":"RD Astronomo","year":"2010","unstructured":"Astronomo RD, Kaltgrad E, Udit AK, Wang SK, Doores KJ, Huang CY, Pantophlet R, Paulson JC, Wong CH, Finn MG, Burton DR (2010) Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds. Chem Biol 17(4):357\u2013370. https:\/\/doi.org\/10.1016\/j.chembiol.2010.03.012","journal-title":"Chem Biol"},{"issue":"11","key":"103_CR6","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1016\/j.celrep.2016.02.058","volume":"14","author":"AJ Behrens","year":"2016","unstructured":"Behrens AJ, Vasiljevic S, Pritchard LK, Harvey DJ, Andev RS, Krumm SA, Struwe WB, Cupo A, Kumar A, Zitzmann N, Seabright GE, Kramer HB, Spencer DI, Royle L, Lee JH, Klasse PJ, Burton DR, Wilson IA, Ward AB, Sanders RW, Moore JP, Doores KJ, Crispin M (2016) Composition and antigenic effects of individual glycan sites of a trimeric HIV-1 envelope glycoprotein. Cell Rep 14(11):2695\u20132706. https:\/\/doi.org\/10.1016\/j.celrep.2016.02.058","journal-title":"Cell Rep"},{"issue":"9","key":"103_CR7","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/eji.200526146","volume":"35","author":"L Benatuil","year":"2005","unstructured":"Benatuil L, Kaye J, Rich RF, Fishman JA, Green WR, Iacomini J (2005) The influence of natural antibody specificity on antigen immunogenicity. Eur J Immunol 35(9):2638\u20132647. https:\/\/doi.org\/10.1002\/eji.200526146","journal-title":"Eur J Immunol"},{"issue":"2","key":"103_CR8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/JVI.74.2.627-643.2000","volume":"74","author":"JM Binley","year":"2000","unstructured":"Binley JM, Sanders RW, Clas B, Schuelke N, Master A, Guo Y, Kajumo F, Anselma DJ, Maddon PJ, Olson WC, Moore JP (2000) A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure. J Virol 74(2):627\u2013643","journal-title":"J Virol"},{"issue":"8","key":"103_CR9","doi-asserted-by":"publisher","first-page":"e23521","DOI":"10.1371\/journal.pone.0023521","volume":"6","author":"C Bonomelli","year":"2011","unstructured":"Bonomelli C, Doores KJ, Dunlop DC, Thaney V, Dwek RA, Burton DR, Crispin M, Scanlan CN (2011) The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade. PLoS ONE 6(8):e23521. https:\/\/doi.org\/10.1371\/journal.pone.0023521","journal-title":"PLoS ONE"},{"issue":"8","key":"103_CR10","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/bies.20441","volume":"28","author":"SM Bowman","year":"2006","unstructured":"Bowman SM, Free SJ (2006) The structure and synthesis of the fungal cell wall. BioEssays 28(8):799\u2013808. https:\/\/doi.org\/10.1002\/bies.20441","journal-title":"BioEssays"},{"issue":"4","key":"103_CR11","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.4049\/jimmunol.0900961","volume":"183","author":"S Bozza","year":"2009","unstructured":"Bozza S, Clavaud C, Giovannini G, Fontaine T, Beauvais A, Sarfati J, D\u2019Angelo C, Perruccio K, Bonifazi P, Zagarella S, Moretti S, Bistoni F, Latge JP, Romani L (2009) Immune sensing of Aspergillus fumigatus proteins, glycolipids, and polysaccharides and the impact on Th immunity and vaccination. J Immunol 183(4):2407\u20132414. https:\/\/doi.org\/10.4049\/jimmunol.0900961","journal-title":"J Immunol"},{"issue":"14","key":"103_CR12","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1016\/j.vaccine.2010.01.012","volume":"28","author":"C Bromuro","year":"2010","unstructured":"Bromuro C, Romano M, Chiani P, Berti F, Tontini M, Proietti D, Mori E, Torosantucci A, Costantino P, Rappuoli R, Cassone A (2010) Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine 28(14):2615\u20132623. https:\/\/doi.org\/10.1016\/j.vaccine.2010.01.012","journal-title":"Vaccine"},{"issue":"10","key":"103_CR13","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nrmicro3480","volume":"13","author":"L Brown","year":"2015","unstructured":"Brown L, Wolf JM, Prados-Rosales R, Casadevall A (2015) Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi. Nat Rev Microbiol 13(10):620\u2013630. https:\/\/doi.org\/10.1038\/nrmicro3480","journal-title":"Nat Rev Microbiol"},{"issue":"5628","key":"103_CR14","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1126\/science.1083182","volume":"300","author":"DA Calarese","year":"2003","unstructured":"Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, Wilson IA (2003) Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science 300(5628):2065\u20132071. https:\/\/doi.org\/10.1126\/science.1083182","journal-title":"Science"},{"issue":"27","key":"103_CR15","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.1016\/j.vaccine.2009.03.030","volume":"27","author":"J Capilla","year":"2009","unstructured":"Capilla J, Clemons KV, Liu M, Levine HB, Stevens DA (2009) Saccharomyces cerevisiae as a vaccine against coccidioidomycosis. Vaccine 27(27):3662\u20133668. https:\/\/doi.org\/10.1016\/j.vaccine.2009.03.030","journal-title":"Vaccine"},{"issue":"1","key":"103_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.molmed.2005.11.003","volume":"12","author":"A Casadevall","year":"2006","unstructured":"Casadevall A, Pirofski LA (2006) Polysaccharide-containing conjugate vaccines for fungal diseases. Trends Mol Med 12(1):6\u20139. https:\/\/doi.org\/10.1016\/j.molmed.2005.11.003","journal-title":"Trends Mol Med"},{"issue":"6","key":"103_CR17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/AAC.42.6.1437","volume":"42","author":"A Casadevall","year":"1998","unstructured":"Casadevall A, Cleare W, Feldmesser M, Glatman-Freedman A, Goldman DL, Kozel TR, Lendvai N, Mukherjee J, Pirofski LA, Rivera J, Rosas AL, Scharff MD, Valadon P, Westin K, Zhong Z (1998) Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies. Antimicrob Agents Chemother 42(6):1437\u20131446","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"103_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/nrmicro3156","volume":"11","author":"A Cassone","year":"2013","unstructured":"Cassone A (2013) Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol 11(12):884\u2013891. https:\/\/doi.org\/10.1038\/nrmicro3156","journal-title":"Nat Rev Microbiol"},{"issue":"12","key":"103_CR19","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1086\/657417","volume":"202","author":"A Cassone","year":"2010","unstructured":"Cassone A, Bromuro C, Chiani P, Torosantucci A (2010) Hyr1 protein and beta-glucan conjugates as anti-Candida vaccines. J Infect Dis 202(12):1930. https:\/\/doi.org\/10.1086\/657417","journal-title":"J Infect Dis"},{"issue":"1\u20132","key":"103_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-3542(02)00202-4","volume":"57","author":"RN Charrel","year":"2003","unstructured":"Charrel RN, de Lamballerie X (2003) Arenaviruses other than Lassa virus. Antiviral Res 57(1\u20132):89\u2013100","journal-title":"Antiviral Res"},{"issue":"5","key":"103_CR21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1128\/IAI.62.5.1507-1512.1994","volume":"62","author":"R Cherniak","year":"1994","unstructured":"Cherniak R, Sundstrom JB (1994) Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 62(5):1507\u20131512","journal-title":"Infect Immun"},{"issue":"10","key":"103_CR22","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/j.vaccine.2010.12.134","volume":"29","author":"SK Chow","year":"2011","unstructured":"Chow SK, Casadevall A (2011) Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. Vaccine 29(10):1891\u20131898. https:\/\/doi.org\/10.1016\/j.vaccine.2010.12.134","journal-title":"Vaccine"},{"issue":"24","key":"103_CR23","doi-asserted-by":"publisher","first-page":"11132","DOI":"10.1128\/JVI.01542-16","volume":"90","author":"KP Coss","year":"2016","unstructured":"Coss KP, Vasiljevic S, Pritchard LK, Krumm SA, Glaze M, Madzorera S, Moore PL, Crispin M, Doores KJ (2016) HIV-1 glycan density drives the persistence of the mannose patch within an infected individual. J Virol 90(24):11132\u201311144. https:\/\/doi.org\/10.1128\/JVI.01542-16","journal-title":"J Virol"},{"key":"103_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.coviro.2015.02.002","volume":"11","author":"M Crispin","year":"2015","unstructured":"Crispin M, Doores KJ (2015) Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design. Curr Opin Virol 11:63\u201369. https:\/\/doi.org\/10.1016\/j.coviro.2015.02.002","journal-title":"Curr Opin Virol"},{"issue":"5","key":"103_CR25","doi-asserted-by":"publisher","first-page":"130002","DOI":"10.1098\/rsob.130002","volume":"3","author":"J Cuccui","year":"2013","unstructured":"Cuccui J, Thomas RM, Moule MG, D\u2019Elia RV, Laws TR, Mills DC, Williamson D, Atkins TP, Prior JL, Wren BW (2013) Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis. Open Biol 3(5):130002. https:\/\/doi.org\/10.1098\/rsob.130002","journal-title":"Open Biol"},{"key":"103_CR26","unstructured":"Cummings RD, Doering TL (2009) Fungi. In: Essentials of glycobiology, vol 2. Cold Spring Harbor Laboratory Press"},{"issue":"1","key":"103_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/hv.2.1.2494","volume":"2","author":"MG Cusi","year":"2006","unstructured":"Cusi MG (2006) Applications of influenza virosomes as a delivery system. Hum Vaccin 2(1):1\u20137","journal-title":"Hum Vaccin"},{"issue":"30","key":"103_CR28","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.vaccine.2012.04.069","volume":"30","author":"F De Bernardis","year":"2012","unstructured":"De Bernardis F, Amacker M, Arancia S, Sandini S, Gremion C, Zurbriggen R, Moser C, Cassone A (2012) A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models. Vaccine 30(30):4490\u20134498. https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.069","journal-title":"Vaccine"},{"issue":"4","key":"103_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3390\/pathogens4040697","volume":"4","author":"F De Bernardis","year":"2015","unstructured":"De Bernardis F, Arancia S, Sandini S, Graziani S, Norelli S (2015) Studies of immune responses in candida vaginitis. Pathogens 4(4):697\u2013707. https:\/\/doi.org\/10.3390\/pathogens4040697","journal-title":"Pathogens"},{"issue":"1","key":"103_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10719-007-9100-x","volume":"25","author":"AR de Boer","year":"2008","unstructured":"de Boer AR, Hokke CH, Deelder AM, Wuhrer M (2008) Serum antibody screening by surface plasmon resonance using a natural glycan microarray. Glycoconj J 25(1):75\u201384. https:\/\/doi.org\/10.1007\/s10719-007-9100-x","journal-title":"Glycoconj J"},{"issue":"1","key":"103_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/QCO.0000000000000225","volume":"29","author":"GJ de Bree","year":"2016","unstructured":"de Bree GJ, Lynch RM (2016) B cells in HIV pathogenesis. Curr Opin Infect Dis 29(1):23\u201330. https:\/\/doi.org\/10.1097\/QCO.0000000000000225","journal-title":"Curr Opin Infect Dis"},{"key":"103_CR32","doi-asserted-by":"publisher","unstructured":"de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN, Donovan BM, Giang E, Krishnan A, Chiriboga L, Charlton MR, Burton DR, Baltimore D, Law M, Rice CM, Ploss A (2014) Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med 6(254):254ra129. https:\/\/doi.org\/10.1126\/scitranslmed.3009512","DOI":"10.1126\/scitranslmed.3009512"},{"issue":"12","key":"103_CR33","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/infdis\/jir173","volume":"203","author":"W Dejnirattisai","year":"2011","unstructured":"Dejnirattisai W, Webb AI, Chan V, Jumnainsong A, Davidson A, Mongkolsapaya J, Screaton G (2011) Lectin switching during dengue virus infection. J Infect Dis 203(12):1775\u20131783. https:\/\/doi.org\/10.1093\/infdis\/jir173","journal-title":"J Infect Dis"},{"issue":"1","key":"103_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-3024.1990.tb00933.x","volume":"12","author":"V Delgado","year":"1990","unstructured":"Delgado V, McLaren DJ (1990) Evidence for enhancement of IgG1 subclass expression in mice polyvaccinated with radiation-attenuated cercariae of Schistosoma mansoni and the role of this isotype in serum-transferred immunity. Parasite Immunol 12(1):15\u201332","journal-title":"Parasite Immunol"},{"issue":"10","key":"103_CR35","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/IAI.59.10.3700-3707.1991","volume":"59","author":"SJ Devi","year":"1991","unstructured":"Devi SJ, Schneerson R, Egan W, Ulrich TJ, Bryla D, Robbins JB, Bennett JE (1991) Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun 59(10):3700\u20133707","journal-title":"Infect Immun"},{"issue":"6","key":"103_CR36","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1128\/IAI.01311-10","volume":"79","author":"D Diaz-Arevalo","year":"2011","unstructured":"Diaz-Arevalo D, Bagramyan K, Hong TB, Ito JI, Kalkum M (2011) CD4+\u2009T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine. Infect Immun 79(6):2257\u20132266. https:\/\/doi.org\/10.1128\/IAI.01311-10","journal-title":"Infect Immun"},{"issue":"1","key":"103_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2012.02.001","volume":"73","author":"D Diekema","year":"2012","unstructured":"Diekema D, Arbefeville S, Boyken L, Kroeger J, Pfaller M (2012) The changing epidemiology of healthcare-associated candidemia over three decades. Diagn Microbiol Infect Dis 73(1):45\u201348. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2012.02.001","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"22","key":"103_CR38","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0264-410X(99)00089-4","volume":"17","author":"DH Dockrell","year":"1999","unstructured":"Dockrell DH, Poland GA, Steckelberg JM, Wollan PC, Strickland SR, Pomeroy C (1999) Immunogenicity of three Haemophilus influenzae type b protein conjugate vaccines in HIV seropositive adults and analysis of predictors of vaccine response. Vaccine 17(22):2779\u20132785","journal-title":"Vaccine"},{"issue":"31","key":"103_CR39","doi-asserted-by":"publisher","first-page":"13800","DOI":"10.1073\/pnas.1006498107","volume":"107","author":"KJ Doores","year":"2010","unstructured":"Doores KJ, Bonomelli C, Harvey DJ, Vasiljevic S, Dwek RA, Burton DR, Crispin M, Scanlan CN (2010a) Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. Proc Natl Acad Sci U S A 107(31):13800\u201313805. https:\/\/doi.org\/10.1073\/pnas.1006498107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"40","key":"103_CR40","doi-asserted-by":"publisher","first-page":"17107","DOI":"10.1073\/pnas.1002717107","volume":"107","author":"KJ Doores","year":"2010","unstructured":"Doores KJ, Fulton Z, Hong V, Patel MK, Scanlan CN, Wormald MR, Finn MG, Burton DR, Wilson IA, Davis BG (2010b) A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity. Proc Natl Acad Sci U S A 107(40):17107\u201317112. https:\/\/doi.org\/10.1073\/pnas.1002717107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"103_CR41","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1128\/JVI.02905-14","volume":"89","author":"KJ Doores","year":"2015","unstructured":"Doores KJ, Kong L, Krumm SA, Le KM, Sok D, Laserson U, Garces F, Poignard P, Wilson IA, Burton DR (2015) Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope. J Virol 89(2):1105\u20131118. https:\/\/doi.org\/10.1128\/JVI.02905-14","journal-title":"J Virol"},{"issue":"7","key":"103_CR42","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.cell.2015.06.003","volume":"161","author":"P Dosenovic","year":"2015","unstructured":"Dosenovic P, von Boehmer L, Escolano A, Jardine J, Freund NT, Gitlin AD, McGuire AT, Kulp DW, Oliveira T, Scharf L, Pietzsch J, Gray MD, Cupo A, van Gils MJ, Yao KH, Liu C, Gazumyan A, Seaman MS, Bjorkman PJ, Sanders RW, Moore JP, Stamatatos L, Schief WR, Nussenzweig MC (2015) Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice. Cell 161(7):1505\u20131515. https:\/\/doi.org\/10.1016\/j.cell.2015.06.003","journal-title":"Cell"},{"issue":"29","key":"103_CR43","doi-asserted-by":"publisher","first-page":"30066","DOI":"10.1074\/jbc.M405098200","volume":"279","author":"HE Drummer","year":"2004","unstructured":"Drummer HE, Poumbourios P (2004) Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. J Biol Chem 279(29):30066\u201330072. https:\/\/doi.org\/10.1074\/jbc.M405098200","journal-title":"J Biol Chem"},{"issue":"9","key":"103_CR44","doi-asserted-by":"crossref","first-page":"5352","DOI":"10.1128\/IAI.69.9.5352-5362.2001","volume":"69","author":"M Eberl","year":"2001","unstructured":"Eberl M, Langermans JA, Frost PA, Vervenne RA, van Dam GJ, Deelder AM, Thomas AW, Coulson PS, Wilson RA (2001a) Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 69(9):5352\u20135362","journal-title":"Infect Immun"},{"issue":"8","key":"103_CR45","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1086\/319691","volume":"183","author":"M Eberl","year":"2001","unstructured":"Eberl M, Langermans JA, Vervenne RA, Nyame AK, Cummings RD, Thomas AW, Coulson PS, Wilson RA (2001b) Antibodies to glycans dominate the host response to schistosome larvae and eggs: is their role protective or subversive? J Infect Dis 183(8):1238\u20131247. https:\/\/doi.org\/10.1086\/319691","journal-title":"J Infect Dis"},{"issue":"2","key":"103_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.virol.2010.02.019","volume":"401","author":"D Eggink","year":"2010","unstructured":"Eggink D, Melchers M, Wuhrer M, van Montfort T, Dey AK, Naaijkens BA, David KB, Le Douce V, Deelder AM, Kang K, Olson WC, Berkhout B, Hokke CH, Moore JP, Sanders RW (2010) Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function. Virology 401(2):236\u2013247. https:\/\/doi.org\/10.1016\/j.virol.2010.02.019","journal-title":"Virology"},{"issue":"2","key":"103_CR47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/0929867043456188","volume":"11","author":"PM Ellerbroek","year":"2004","unstructured":"Ellerbroek PM, Walenkamp AM, Hoepelman AI, Coenjaerts FE (2004) Effects of the capsular polysaccharides of Cryptococcus neoformans on phagocyte migration and inflammatory mediators. Curr Med Chem 11(2):253\u2013266","journal-title":"Curr Med Chem"},{"issue":"5","key":"103_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.immuni.2014.04.009","volume":"40","author":"E Falkowska","year":"2014","unstructured":"Falkowska E, Le KM, Ramos A, Doores KJ, Lee JH, Blattner C, Ramirez A, Derking R, van Gils MJ, Liang CH, McBride R, von Bredow B, Shivatare SS, Wu CY, Chan-Hui PY, Liu Y, Feizi T, Zwick MB, Koff WC, Seaman MS, Swiderek K, Moore JP, Evans D, Paulson JC, Wong CH, Ward AB, Wilson IA, Sanders RW, Poignard P, Burton DR (2014) Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers. Immunity 40(5):657\u2013668. https:\/\/doi.org\/10.1016\/j.immuni.2014.04.009","journal-title":"Immunity"},{"issue":"3","key":"103_CR49","first-page":"397","volume":"15","author":"F Fenner","year":"1993","unstructured":"Fenner F (1993) Smallpox: emergence, global spread, and eradication. Hist Philos Life Sci 15(3):397\u2013420","journal-title":"Hist Philos Life Sci"},{"issue":"8346","key":"103_CR50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(83)90340-9","volume":"2","author":"J Finne","year":"1983","unstructured":"Finne J, Leinonen M, Makela PH (1983) Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 2(8346):355\u2013357","journal-title":"Lancet"},{"issue":"3","key":"103_CR51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1128\/AEM.01901-10","volume":"77","author":"AC Fisher","year":"2011","unstructured":"Fisher AC, Haitjema CH, Guarino C, Celik E, Endicott CE, Reading CA, Merritt JH, Ptak AC, Zhang S, DeLisa MP (2011) Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. Appl Environ Microbiol 77(3):871\u2013881. https:\/\/doi.org\/10.1128\/AEM.01901-10","journal-title":"Appl Environ Microbiol"},{"issue":"2","key":"103_CR52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.4049\/jimmunol.166.2.1087","volume":"166","author":"R Fleuridor","year":"2001","unstructured":"Fleuridor R, Lees A, Pirofski L (2001) A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. J Immunol 166(2):1087\u20131096","journal-title":"J Immunol"},{"key":"103_CR53","doi-asserted-by":"publisher","unstructured":"Flynn NM, Forthal DN, Harro CD, Judson FN, Mayer KH, Para MF, rgp HIVVSG (2005) Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. J Infect Dis 191 (5):654\u2013665. https:\/\/doi.org\/10.1086\/428404","DOI":"10.1086\/428404"},{"issue":"9","key":"103_CR54","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1128\/IAI.59.9.2922-2928.1991","volume":"59","author":"AH Fortier","year":"1991","unstructured":"Fortier AH, Slayter MV, Ziemba R, Meltzer MS, Nacy CA (1991) Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun 59(9):2922\u20132928","journal-title":"Infect Immun"},{"issue":"2\u20133","key":"103_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12026-011-8226-x","volume":"50","author":"SL Gaffen","year":"2011","unstructured":"Gaffen SL, Hernandez-Santos N, Peterson AC (2011) IL-17 signaling in host defense against Candida albicans. Immunol Res 50(2\u20133):181\u2013187. https:\/\/doi.org\/10.1007\/s12026-011-8226-x","journal-title":"Immunol Res"},{"issue":"8","key":"103_CR56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/00007890-199804270-00020","volume":"65","author":"U Galili","year":"1998","unstructured":"Galili U, LaTemple DC, Radic MZ (1998) A sensitive assay for measuring alpha-Gal epitope expression on cells by a monoclonal anti-Gal antibody. Transplantation 65(8):1129\u20131132","journal-title":"Transplantation"},{"issue":"3","key":"103_CR57","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1021\/pr300870t","volume":"12","author":"EP Go","year":"2013","unstructured":"Go EP, Liao HX, Alam SM, Hua D, Haynes BF, Desaire H (2013) Characterization of host-cell line specific glycosylation profiles of early transmitted\/founder HIV-1 gp120 envelope proteins. J Proteome Res 12(3):1223\u20131234. https:\/\/doi.org\/10.1021\/pr300870t","journal-title":"J Proteome Res"},{"issue":"1","key":"103_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2249.2000.01109.x","volume":"119","author":"D Goldblatt","year":"2000","unstructured":"Goldblatt D (2000) Conjugate vaccines. Clin Exp Immunol 119(1):1\u20133","journal-title":"Clin Exp Immunol"},{"issue":"19","key":"103_CR59","doi-asserted-by":"publisher","first-page":"10857","DOI":"10.1128\/JVI.01414-12","volume":"86","author":"L Goo","year":"2012","unstructured":"Goo L, Jalalian-Lechak Z, Richardson BA, Overbaugh J (2012) A combination of broadly neutralizing HIV-1 monoclonal antibodies targeting distinct epitopes effectively neutralizes variants found in early infection. J Virol 86(19):10857\u201310861. https:\/\/doi.org\/10.1128\/JVI.01414-12","journal-title":"J Virol"},{"key":"103_CR60","doi-asserted-by":"publisher","unstructured":"Graves P, Gelband H (2003) Vaccines for preventing malaria. Cochrane Database Syst Rev (1):CD000129. https:\/\/doi.org\/10.1002\/14651858.cd000129","DOI":"10.1002\/14651858.cd000129"},{"issue":"Pt 9","key":"103_CR61","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1099\/vir.0.012120-0","volume":"90","author":"K Hacker","year":"2009","unstructured":"Hacker K, White L, de Silva AM (2009) N-linked glycans on dengue viruses grown in mammalian and insect cells. J Gen Virol 90(Pt 9):2097\u20132106. https:\/\/doi.org\/10.1099\/vir.0.012120-0","journal-title":"J Gen Virol"},{"issue":"8","key":"103_CR62","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1517\/14712598.3.8.1271","volume":"3","author":"P Hagan","year":"2003","unstructured":"Hagan P, Sharaf O (2003) Schistosomiasis vaccines. Expert Opin Biol Ther 3(8):1271\u20131278. https:\/\/doi.org\/10.1517\/14712598.3.8.1271","journal-title":"Expert Opin Biol Ther"},{"issue":"36","key":"103_CR63","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1016\/j.vaccine.2015.06.102","volume":"33","author":"CF Hatz","year":"2015","unstructured":"Hatz CF, Bally B, Rohrer S, Steffen R, Kramme S, Siegrist CA, Wacker M, Alaimo C, Fonck VG (2015) Safety and immunogenicity of a candidate bioconjugate vaccine against Shigella dysenteriae type 1 administered to healthy adults: a single blind, partially randomized Phase I study. Vaccine 33(36):4594\u20134601. https:\/\/doi.org\/10.1016\/j.vaccine.2015.06.102","journal-title":"Vaccine"},{"issue":"1","key":"103_CR64","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.38.1.73","volume":"38","author":"M Heidelberger","year":"1923","unstructured":"Heidelberger M, Avery OT (1923) The soluble specific substance of pneumococcus. J Exp Med 38(1):73\u201379","journal-title":"J Exp Med"},{"issue":"5","key":"103_CR65","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.65.5.535","volume":"65","author":"M Heidelberger","year":"1950","unstructured":"Heidelberger M, Dilapi MM, Siegel M, Walter AW (1950) Persistence of antibodies in human subjects injected with pneumococcal polysaccharides. J Immunol 65(5):535\u2013541","journal-title":"J Immunol"},{"issue":"10","key":"103_CR66","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1128\/JCM.33.10.2759-2762.1995","volume":"33","author":"J Henrichsen","year":"1995","unstructured":"Henrichsen J (1995) Six newly recognized types of Streptococcus pneumoniae. J Clin Microbiol 33(10):2759\u20132762","journal-title":"J Clin Microbiol"},{"issue":"4","key":"103_CR67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1586\/14760584.2014.893195","volume":"13","author":"JP Hewitson","year":"2014","unstructured":"Hewitson JP, Maizels RM (2014) Vaccination against helminth parasite infections. Expert Rev Vaccines 13(4):473\u2013487. https:\/\/doi.org\/10.1586\/14760584.2014.893195","journal-title":"Expert Rev Vaccines"},{"issue":"7\u20138","key":"103_CR68","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-3024.2005.00764.x","volume":"27","author":"JP Hewitson","year":"2005","unstructured":"Hewitson JP, Hamblin PA, Mountford AP (2005) Immunity induced by the radiation-attenuated schistosome vaccine. Parasite Immunol 27(7\u20138):271\u2013280. https:\/\/doi.org\/10.1111\/j.1365-3024.2005.00764.x","journal-title":"Parasite Immunol"},{"issue":"45","key":"103_CR69","doi-asserted-by":"crossref","first-page":"13434","DOI":"10.1021\/ja027538k","volume":"124","author":"MC Hewitt","year":"2002","unstructured":"Hewitt MC, Snyder DA, Seeberger PH (2002) Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesis. J Am Chem Soc 124(45):13434\u201313436","journal-title":"J Am Chem Soc"},{"issue":"8","key":"103_CR70","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1023\/A:1020634602161","volume":"18","author":"CH Hokke","year":"2001","unstructured":"Hokke CH, Deelder AM (2001) Schistosome glycoconjugates in host-parasite interplay. Glycoconj J 18(8):573\u2013587","journal-title":"Glycoconj J"},{"issue":"7525","key":"103_CR71","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/nature13601","volume":"515","author":"J Huang","year":"2014","unstructured":"Huang J, Kang BH, Pancera M, Lee JH, Tong T, Feng Y, Imamichi H, Georgiev IS, Chuang GY, Druz A, Doria-Rose NA, Laub L, Sliepen K, van Gils MJ, de la Pena AT, Derking R, Klasse PJ, Migueles SA, Bailer RT, Alam M, Pugach P, Haynes BF, Wyatt RT, Sanders RW, Binley JM, Ward AB, Mascola JR, Kwong PD, Connors M (2014) Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface. Nature 515(7525):138\u2013142. https:\/\/doi.org\/10.1038\/nature13601","journal-title":"Nature"},{"issue":"6","key":"103_CR72","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1086\/342509","volume":"186","author":"JI Ito","year":"2002","unstructured":"Ito JI, Lyons JM (2002) Vaccination of corticosteroid immunosuppressed mice against invasive pulmonary aspergillosis. J Infect Dis 186(6):869\u2013871. https:\/\/doi.org\/10.1086\/342509","journal-title":"J Infect Dis"},{"issue":"9","key":"103_CR73","doi-asserted-by":"publisher","first-page":"5075","DOI":"10.1128\/IAI.00815-06","volume":"74","author":"JI Ito","year":"2006","unstructured":"Ito JI, Lyons JM, Hong TB, Tamae D, Liu YK, Wilczynski SP, Kalkum M (2006) Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis. Infect Immun 74(9):5075\u20135084. https:\/\/doi.org\/10.1128\/IAI.00815-06","journal-title":"Infect Immun"},{"issue":"6133","key":"103_CR74","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1126\/science.1234150","volume":"340","author":"J Jardine","year":"2013","unstructured":"Jardine J, Julien JP, Menis S, Ota T, Kalyuzhniy O, McGuire A, Sok D, Huang PS, MacPherson S, Jones M, Nieusma T, Mathison J, Baker D, Ward AB, Burton DR, Stamatatos L, Nemazee D, Wilson IA, Schief WR (2013) Rational HIV immunogen design to target specific germline B cell receptors. Science 340(6133):711\u2013716. https:\/\/doi.org\/10.1126\/science.1234150","journal-title":"Science"},{"key":"103_CR75","doi-asserted-by":"publisher","unstructured":"Jardine JG, Ota T, Sok D, Pauthner M, Kulp DW, Kalyuzhniy O, Skog PD, Thinnes TC, Bhullar D, Briney B, Menis S, Jones M, Kubitz M, Spencer S, Adachi Y, Burton DR, Schief WR, Nemazee D (2015) HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349(6244):156\u2013161. https:\/\/doi.org\/10.1126\/science.aac5894","DOI":"10.1126\/science.aac5894"},{"issue":"6280","key":"103_CR76","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.aad9195","volume":"351","author":"JG Jardine","year":"2016","unstructured":"Jardine JG, Kulp DW, Havenar-Daughton C, Sarkar A, Briney B, Sok D, Sesterhenn F, Ereno-Orbea J, Kalyuzhniy O, Deresa I, Hu X, Spencer S, Jones M, Georgeson E, Adachi Y, Kubitz M, deCamp AC, Julien JP, Wilson IA, Burton DR, Crotty S, Schief WR (2016) HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen. Science 351(6280):1458\u20131463. https:\/\/doi.org\/10.1126\/science.aad9195","journal-title":"Science"},{"issue":"10","key":"103_CR77","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.1039\/c2cs35382b","volume":"42","author":"MA Johnson","year":"2013","unstructured":"Johnson MA, Bundle DR (2013) Designing a new antifungal glycoconjugate vaccine. Chem Soc Rev 42(10):4327\u20134344. https:\/\/doi.org\/10.1039\/c2cs35382b","journal-title":"Chem Soc Rev"},{"issue":"6165","key":"103_CR78","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1126\/science.1245625","volume":"342","author":"JP Julien","year":"2013","unstructured":"Julien JP, Cupo A, Sok D, Stanfield RL, Lyumkis D, Deller MC, Klasse PJ, Burton DR, Sanders RW, Moore JP, Ward AB, Wilson IA (2013a) Crystal structure of a soluble cleaved HIV-1 envelope trimer. Science 342(6165):1477\u20131483. https:\/\/doi.org\/10.1126\/science.1245625","journal-title":"Science"},{"issue":"11","key":"103_CR79","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.1073\/pnas.1217537110","volume":"110","author":"JP Julien","year":"2013","unstructured":"Julien JP, Lee JH, Cupo A, Murin CD, Derking R, Hoffenberg S, Caulfield MJ, King CR, Marozsan AJ, Klasse PJ, Sanders RW, Moore JP, Wilson IA, Ward AB (2013b) Asymmetric recognition of the HIV-1 trimer by broadly neutralizing antibody PG9. Proc Natl Acad Sci U S A 110(11):4351\u20134356. https:\/\/doi.org\/10.1073\/pnas.1217537110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"103_CR80","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrmicro1688","volume":"5","author":"SH Kaufmann","year":"2007","unstructured":"Kaufmann SH (2007) The contribution of immunology to the rational design of novel antibacterial vaccines. Nat Rev Microbiol 5(7):491\u2013504. https:\/\/doi.org\/10.1038\/nrmicro1688","journal-title":"Nat Rev Microbiol"},{"issue":"17","key":"103_CR81","doi-asserted-by":"publisher","first-page":"9865","DOI":"10.1128\/JVI.01222-13","volume":"87","author":"R Khayat","year":"2013","unstructured":"Khayat R, Lee JH, Julien JP, Cupo A, Klasse PJ, Sanders RW, Moore JP, Wilson IA, Ward AB (2013) Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers. J Virol 87(17):9865\u20139872. https:\/\/doi.org\/10.1128\/JVI.01222-13","journal-title":"J Virol"},{"issue":"8","key":"103_CR82","doi-asserted-by":"publisher","first-page":"941","DOI":"10.2217\/FMB.11.72","volume":"6","author":"FM Klis","year":"2011","unstructured":"Klis FM, de Koster CG, Brul S (2011) A mass spectrometric view of the fungal wall proteome. Future Microbiol 6(8):941\u2013951. https:\/\/doi.org\/10.2217\/FMB.11.72","journal-title":"Future Microbiol"},{"issue":"7","key":"103_CR83","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nsmb.2594","volume":"20","author":"L Kong","year":"2013","unstructured":"Kong L, Lee JH, Doores KJ, Murin CD, Julien JP, McBride R, Liu Y, Marozsan A, Cupo A, Klasse PJ, Hoffenberg S, Caulfield M, King CR, Hua Y, Le KM, Khayat R, Deller MC, Clayton T, Tien H, Feizi T, Sanders RW, Paulson JC, Moore JP, Stanfield RL, Burton DR, Ward AB, Wilson IA (2013) Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120. Nat Struct Mol Biol 20(7):796\u2013803. https:\/\/doi.org\/10.1038\/nsmb.2594","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"103_CR84","first-page":"651","volume":"77","author":"KL Kotloff","year":"1999","unstructured":"Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM (1999) Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ 77(8):651\u2013666","journal-title":"Bull World Health Organ"},{"issue":"1","key":"103_CR85","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12977-016-0241-5","volume":"13","author":"SA Krumm","year":"2016","unstructured":"Krumm SA, Mohammed H, Le KM, Crispin M, Wrin T, Poignard P, Burton DR, Doores KJ (2016) Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies. Retrovirology 13(1):8. https:\/\/doi.org\/10.1186\/s12977-016-0241-5","journal-title":"Retrovirology"},{"issue":"9","key":"103_CR86","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/nri3516","volume":"13","author":"PD Kwong","year":"2013","unstructured":"Kwong PD, Mascola JR, Nabel GJ (2013) Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning. Nat Rev Immunol 13(9):693\u2013701. https:\/\/doi.org\/10.1038\/nri3516","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"103_CR87","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.4049\/jimmunol.175.11.7496","volume":"175","author":"JS Lam","year":"2005","unstructured":"Lam JS, Mansour MK, Specht CA, Levitz SM (2005) A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 175(11):7496\u20137503","journal-title":"J Immunol"},{"issue":"3","key":"103_CR88","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1128\/AAC.49.3.952-958.2005","volume":"49","author":"RA Larsen","year":"2005","unstructured":"Larsen RA, Pappas PG, Perfect J, Aberg JA, Casadevall A, Cloud GA, James R, Filler S, Dismukes WE (2005) Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated Cryptococcal meningitis. Antimicrob Agents Chemother 49(3):952\u2013958. https:\/\/doi.org\/10.1128\/AAC.49.3.952-958.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"103_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nm1698","volume":"14","author":"M Law","year":"2008","unstructured":"Law M, Maruyama T, Lewis J, Giang E, Tarr AW, Stamataki Z, Gastaminza P, Chisari FV, Jones IM, Fox RI, Ball JK, McKeating JA, Kneteman NM, Burton DR (2008) Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nat Med 14(1):25\u201327. https:\/\/doi.org\/10.1038\/nm1698","journal-title":"Nat Med"},{"issue":"5","key":"103_CR90","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0609.2004.00216.x","volume":"72","author":"TF Leung","year":"2004","unstructured":"Leung TF, Li CK, Hung EC, Chan PK, Mo CW, Wong RP, Chik KW (2004) Immunogenicity of a two-dose regime of varicella vaccine in children with cancers. Eur J Haematol 72(5):353\u2013357. https:\/\/doi.org\/10.1111\/j.1600-0609.2004.00216.x","journal-title":"Eur J Haematol"},{"issue":"2","key":"103_CR91","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1067\/mpd.2001.115972","volume":"139","author":"MJ Levin","year":"2001","unstructured":"Levin MJ, Gershon AA, Weinberg A, Blanchard S, Nowak B, Palumbo P, Chan CY, Team ACTG (2001) Immunization of HIV-infected children with varicella vaccine. J Pediatr 139(2):305\u2013310. https:\/\/doi.org\/10.1067\/mpd.2001.115972","journal-title":"J Pediatr"},{"issue":"7","key":"103_CR92","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrmicro1662","volume":"5","author":"MM Levine","year":"2007","unstructured":"Levine MM, Kotloff KL, Barry EM, Pasetti MF, Sztein MB (2007) Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road. Nat Rev Microbiol 5(7):540\u2013553. https:\/\/doi.org\/10.1038\/nrmicro1662","journal-title":"Nat Rev Microbiol"},{"issue":"2","key":"103_CR93","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00281-014-0460-6","volume":"37","author":"SM Levitz","year":"2015","unstructured":"Levitz SM, Huang H, Ostroff GR, Specht CA (2015) Exploiting fungal cell wall components in vaccines. Semin Immunopathol 37(2):199\u2013207. https:\/\/doi.org\/10.1007\/s00281-014-0460-6","journal-title":"Semin Immunopathol"},{"issue":"14","key":"103_CR94","doi-asserted-by":"publisher","first-page":"5004","DOI":"10.1021\/ja042374o","volume":"127","author":"X Liu","year":"2005","unstructured":"Liu X, Kwon YU, Seeberger PH (2005) Convergent synthesis of a fully lipidated glycosylphosphatidylinositol anchor of Plasmodium falciparum. J Am Chem Soc 127(14):5004\u20135005. https:\/\/doi.org\/10.1021\/ja042374o","journal-title":"J Am Chem Soc"},{"issue":"Pt 10","key":"103_CR95","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1099\/jmm.0.033290-0","volume":"60","author":"M Liu","year":"2011","unstructured":"Liu M, Capilla J, Johansen ME, Alvarado D, Martinez M, Chen V, Clemons KV, Stevens DA (2011) Saccharomyces as a vaccine against systemic aspergillosis: \u2018the friend of man\u2019 a friend again? J Med Microbiol 60(Pt 10):1423\u20131432. https:\/\/doi.org\/10.1099\/jmm.0.033290-0","journal-title":"J Med Microbiol"},{"issue":"8","key":"103_CR96","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3109\/08820139.2012.692418","volume":"41","author":"MCK Liu","year":"2012","unstructured":"Liu MCK, Johansen ME, Martinez M, Chen V, Stevens DA (2012) Saccharomyces as a vaccine against systemic candidiasis. Immunol Invest 41(8):847\u2013855","journal-title":"Immunol Invest"},{"issue":"11","key":"103_CR97","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1086\/652407","volume":"201","author":"G Luo","year":"2010","unstructured":"Luo G, Ibrahim AS, Spellberg B, Nobile CJ, Mitchell AP, Fu Y (2010) Candida albicans Hyr1p confers resistance to neutrophil killing and is a potential vaccine target. J Infect Dis 201(11):1718\u20131728. https:\/\/doi.org\/10.1086\/652407","journal-title":"J Infect Dis"},{"issue":"22","key":"103_CR98","doi-asserted-by":"publisher","first-page":"4340","DOI":"10.1016\/j.vaccine.2007.03.027","volume":"25","author":"M Luong","year":"2007","unstructured":"Luong M, Lam JS, Chen J, Levitz SM (2007) Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine 25(22):4340\u20134344. https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.027","journal-title":"Vaccine"},{"issue":"7","key":"103_CR99","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/glycob\/cwu029","volume":"24","author":"AE Luyai","year":"2014","unstructured":"Luyai AE, Heimburg-Molinaro J, Prasanphanich NS, Mickum ML, Lasanajak Y, Song X, Nyame AK, Wilkins P, Rivera-Marrero CA, Smith DF, Van Die I, Secor WE, Cummings RD (2014) Differential expression of anti-glycan antibodies in schistosome-infected humans, rhesus monkeys and mice. Glycobiology 24(7):602\u2013618. https:\/\/doi.org\/10.1093\/glycob\/cwu029","journal-title":"Glycobiology"},{"issue":"2","key":"103_CR100","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbagen.2007.11.003","volume":"1780","author":"BA Macher","year":"2008","unstructured":"Macher BA, Galili U (2008) The Galalpha 1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance. Biochim Biophys Acta 1780(2):75\u201388. https:\/\/doi.org\/10.1016\/j.bbagen.2007.11.003","journal-title":"Biochim Biophys Acta"},{"key":"103_CR101","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1146\/annurev.iy.12.040194.001001","volume":"12","author":"IC MacLennan","year":"1994","unstructured":"MacLennan IC (1994) Germinal centers. Annu Rev Immunol 12:117\u2013139. https:\/\/doi.org\/10.1146\/annurev.iy.12.040194.001001","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"103_CR102","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1086\/429828","volume":"40","author":"SA Madhi","year":"2005","unstructured":"Madhi SA, Kuwanda L, Cutland C, Klugman KP (2005) The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 40(10):1511\u20131518. https:\/\/doi.org\/10.1086\/429828","journal-title":"Clin Infect Dis"},{"issue":"3\u20134","key":"103_CR103","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11046-014-9798-5","volume":"178","author":"T Majumder","year":"2014","unstructured":"Majumder T, Liu M, Chen V, Martinez M, Alvarado D, Clemons KV, Stevens DA (2014) Killed Saccharomyces cerevisiae protects against lethal challenge of Cryptococcus grubii. Mycopathologia 178(3\u20134):189\u2013195. https:\/\/doi.org\/10.1007\/s11046-014-9798-5","journal-title":"Mycopathologia"},{"issue":"7","key":"103_CR104","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1093\/glycob\/cwt025","volume":"23","author":"M Mandalasi","year":"2013","unstructured":"Mandalasi M, Dorabawila N, Smith DF, Heimburg-Molinaro J, Cummings RD, Nyame AK (2013) Development and characterization of a specific IgG monoclonal antibody toward the Lewis x antigen using splenocytes of Schistosoma mansoni-infected mice. Glycobiology 23(7):877\u2013892. https:\/\/doi.org\/10.1093\/glycob\/cwt025","journal-title":"Glycobiology"},{"issue":"7377","key":"103_CR105","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nature10696","volume":"480","author":"JS McLellan","year":"2011","unstructured":"McLellan JS, Pancera M, Carrico C, Gorman J, Julien JP, Khayat R, Louder R, Pejchal R, Sastry M, Dai K, O\u2019Dell S, Patel N, Shahzad-ul-Hussan S, Yang Y, Zhang B, Zhou T, Zhu J, Boyington JC, Chuang GY, Diwanji D, Georgiev I, Kwon YD, Lee D, Louder MK, Moquin S, Schmidt SD, Yang ZY, Bonsignori M, Crump JA, Kapiga SH, Sam NE, Haynes BF, Burton DR, Koff WC, Walker LM, Phogat S, Wyatt R, Orwenyo J, Wang LX, Arthos J, Bewley CA, Mascola JR, Nabel GJ, Schief WR, Ward AB, Wilson IA, Kwong PD (2011) Structure of HIV-1 gp120 V1\/V2 domain with broadly neutralizing antibody PG9. Nature 480(7377):336\u2013343. https:\/\/doi.org\/10.1038\/nature10696","journal-title":"Nature"},{"key":"103_CR106","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","volume":"479\u2013480","author":"PD Minor","year":"2015","unstructured":"Minor PD (2015) Live attenuated vaccines: historical successes and current challenges. Virology 479\u2013480:379\u2013392. https:\/\/doi.org\/10.1016\/j.virol.2015.03.032","journal-title":"Virology"},{"issue":"46","key":"103_CR107","doi-asserted-by":"publisher","first-page":"18921","DOI":"10.1073\/pnas.1214785109","volume":"109","author":"B Moldt","year":"2012","unstructured":"Moldt B, Rakasz EG, Schultz N, Chan-Hui PY, Swiderek K, Weisgrau KL, Piaskowski SM, Bergman Z, Watkins DI, Poignard P, Burton DR (2012) Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo. Proc Natl Acad Sci U S A 109(46):18921\u201318925. https:\/\/doi.org\/10.1073\/pnas.1214785109","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"103_CR108","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1586\/14760584.2013.811195","volume":"12","author":"C Moser","year":"2013","unstructured":"Moser C, Muller M, Kaeser MD, Weydemann U, Amacker M (2013) Influenza virosomes as vaccine adjuvant and carrier system. Expert Rev Vaccines 12(7):779\u2013791. https:\/\/doi.org\/10.1586\/14760584.2013.811195","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"103_CR109","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.it.2015.07.001","volume":"36","author":"H Mouquet","year":"2015","unstructured":"Mouquet H (2015) Tailored immunogens for rationally designed antibody-based HIV-1 vaccines. Trends Immunol 36(8):437\u2013439. https:\/\/doi.org\/10.1016\/j.it.2015.07.001","journal-title":"Trends Immunol"},{"key":"103_CR110","doi-asserted-by":"publisher","unstructured":"Mouquet H, Scharf L, Euler Z, Liu Y, Eden C, Scheid JF, Halper-Stromberg A, Gnanapragasam PN, Spencer DI, Seaman MS, Schuitemaker H, Feizi T, Nussenzweig MC, Bjorkman PJ (2012) Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc Natl Acad Sci U S A 109(47):E3268\u2013E3277. https:\/\/doi.org\/10.1073\/pnas.1217207109","DOI":"10.1073\/pnas.1217207109"},{"key":"103_CR111","unstructured":"Moxon ER, Kroll JS (1990) The role of bacterial polysaccharides capsules as virulence factors. In: Jann K, Jann B (eds) Bacterial capsules. pp 65\u201385"},{"issue":"4","key":"103_CR112","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.177.4.1105","volume":"177","author":"J Mukherjee","year":"1993","unstructured":"Mukherjee J, Casadevall A, Scharff MD (1993) Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J Exp Med 177(4):1105\u20131116","journal-title":"J Exp Med"},{"issue":"1","key":"103_CR113","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1084\/jem.181.1.405","volume":"181","author":"J Mukherjee","year":"1995","unstructured":"Mukherjee J, Nussbaum G, Scharff MD, Casadevall A (1995) Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J Exp Med 181(1):405\u2013409","journal-title":"J Exp Med"},{"issue":"2","key":"103_CR114","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1385\/MO:19:2:71","volume":"19","author":"T Nordoy","year":"2002","unstructured":"Nordoy T, Aaberge IS, Husebekk A, Samdal HH, Steinert S, Melby H, Kolstad A (2002) Cancer patients undergoing chemotherapy show adequate serological response to vaccinations against influenza virus and Streptococcus pneumoniae. Med Oncol 19(2):71\u201378. https:\/\/doi.org\/10.1385\/MO:19:2:71","journal-title":"Med Oncol"},{"issue":"2","key":"103_CR115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/IAI.67.2.782-788.1999","volume":"67","author":"FR Noriega","year":"1999","unstructured":"Noriega FR, Liao FM, Maneval DR, Ren S, Formal SB, Levine MM (1999) Strategy for cross-protection among Shigella flexneri serotypes. Infect Immun 67(2):782\u2013788","journal-title":"Infect Immun"},{"issue":"2","key":"103_CR116","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.abb.2004.04.004","volume":"426","author":"AK Nyame","year":"2004","unstructured":"Nyame AK, Kawar ZS, Cummings RD (2004) Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Arch Biochem Biophys 426(2):182\u2013200. https:\/\/doi.org\/10.1016\/j.abb.2004.04.004","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"103_CR117","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.4049\/jimmunol.163.12.6712","volume":"163","author":"M Okano","year":"1999","unstructured":"Okano M, Satoskar AR, Nishizaki K, Abe M, Harn DA Jr (1999) Induction of Th2 responses and IgE is largely due to carbohydrates functioning as adjuvants on Schistosoma mansoni egg antigens. J Immunol 163(12):6712\u20136717","journal-title":"J Immunol"},{"issue":"7","key":"103_CR118","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nsmb.2600","volume":"20","author":"M Pancera","year":"2013","unstructured":"Pancera M, Shahzad-Ul-Hussan S, Doria-Rose NA, McLellan JS, Bailer RT, Dai K, Loesgen S, Louder MK, Staupe RP, Yang Y, Zhang B, Parks R, Eudailey J, Lloyd KE, Blinn J, Alam SM, Haynes BF, Amin MN, Wang LX, Burton DR, Koff WC, Nabel GJ, Mascola JR, Bewley CA, Kwong PD (2013) Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16. Nat Struct Mol Biol 20(7):804\u2013813. https:\/\/doi.org\/10.1038\/nsmb.2600","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"103_CR119","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.idc.2006.07.004","volume":"20","author":"PG Pappas","year":"2006","unstructured":"Pappas PG (2006) Invasive candidiasis. Infect Dis Clin North Am 20(3):485\u2013506. https:\/\/doi.org\/10.1016\/j.idc.2006.07.004","journal-title":"Infect Dis Clin North Am"},{"key":"103_CR120","doi-asserted-by":"publisher","unstructured":"Passwell JH, Ashkenzi S, Banet-Levi Y, Ramon-Saraf R, Farzam N, Lerner-Geva L, Even-Nir H, Yerushalmi B, Chu C, Shiloach J, Robbins JB, Schneerson R, Israeli Shigella Study G (2010) Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1\u20134-year-old Israeli children. Vaccine 28(10):2231\u20132235. https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.050","DOI":"10.1016\/j.vaccine.2009.12.050"},{"issue":"4","key":"103_CR121","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.4049\/jimmunol.0803141","volume":"182","author":"A Phalipon","year":"2009","unstructured":"Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Belot F, Cohen D, Sansonetti PJ, Mulard LA (2009) A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection. J Immunol 182(4):2241\u20132247. https:\/\/doi.org\/10.4049\/jimmunol.0803141","journal-title":"J Immunol"},{"issue":"7","key":"103_CR122","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.vaccine.2009.12.021","volume":"28","author":"D Pietrella","year":"2010","unstructured":"Pietrella D, Rachini A, Torosantucci A, Chiani P, Brown AJ, Bistoni F, Costantino P, Mosci P, d\u2019Enfert C, Rappuoli R, Cassone A, Vecchiarelli A (2010) A beta-glucan-conjugate vaccine and anti-beta-glucan antibodies are effective against murine vaginal candidiasis as assessed by a novel in vivo imaging technique. Vaccine 28(7):1717\u20131725. https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.021","journal-title":"Vaccine"},{"issue":"12","key":"103_CR123","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1086\/508748","volume":"194","author":"P Pitisuttithum","year":"2006","unstructured":"Pitisuttithum P, Gilbert P, Gurwith M, Heyward W, Martin M, van Griensven F, Hu D, Tappero JW, Choopanya K, Bangkok Vaccine Evaluation G (2006) Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok. Thailand. J Infect Dis 194(12):1661\u20131671. https:\/\/doi.org\/10.1086\/508748","journal-title":"Thailand. J Infect Dis"},{"issue":"10","key":"103_CR124","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/j.fgb.2008.08.003","volume":"45","author":"A Plaine","year":"2008","unstructured":"Plaine A, Walker L, Da Costa G, Mora-Montes HM, McKinnon A, Gow NA, Gaillardin C, Munro CA, Richard ML (2008) Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity. Fungal Genet Biol 45(10):1404\u20131414. https:\/\/doi.org\/10.1016\/j.fgb.2008.08.003","journal-title":"Fungal Genet Biol"},{"issue":"2","key":"103_CR125","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/156802608783378864","volume":"8","author":"V Pozsgay","year":"2008","unstructured":"Pozsgay V (2008) Recent developments in synthetic oligosaccharide-based bacterial vaccines. Curr Top Med Chem 8(2):126\u2013140","journal-title":"Curr Top Med Chem"},{"issue":"9","key":"103_CR126","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1073\/pnas.96.9.5194","volume":"96","author":"V Pozsgay","year":"1999","unstructured":"Pozsgay V, Chu C, Pannell L, Wolfe J, Robbins JB, Schneerson R (1999) Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. Proc Natl Acad Sci U S A 96(9):5194\u20135197","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"103_CR127","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/glycob\/cwu027","volume":"24","author":"NS Prasanphanich","year":"2014","unstructured":"Prasanphanich NS, Luyai AE, Song X, Heimburg-Molinaro J, Mandalasi M, Mickum M, Smith DF, Nyame AK, Cummings RD (2014) Immunization with recombinantly expressed glycan antigens from Schistosoma mansoni induces glycan-specific antibodies against the parasite. Glycobiology 24(7):619\u2013637. https:\/\/doi.org\/10.1093\/glycob\/cwu027","journal-title":"Glycobiology"},{"key":"103_CR128","doi-asserted-by":"publisher","unstructured":"Prior JL, Prior RG, Hitchen PG, Diaper H, Griffin KF, Morris HR, Dell A, Titball RW (2003) Characterization of the O antigen gene cluster and structural analysis of the O antigen of Francisella tularensis subsp. tularensis. J Med Microbiol 52(Pt 10):845\u2013851. https:\/\/doi.org\/10.1099\/jmm.0.05184-0","DOI":"10.1099\/jmm.0.05184-0"},{"issue":"10","key":"103_CR129","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.celrep.2015.05.017","volume":"11","author":"LK Pritchard","year":"2015","unstructured":"Pritchard LK, Vasiljevic S, Ozorowski G, Seabright GE, Cupo A, Ringe R, Kim HJ, Sanders RW, Doores KJ, Burton DR, Wilson IA, Ward AB, Moore JP, Crispin M (2015) Structural constraints determine the glycosylation of HIV-1 envelope trimers. Cell Rep 11(10):1604\u20131613. https:\/\/doi.org\/10.1016\/j.celrep.2015.05.017","journal-title":"Cell Rep"},{"issue":"29\u201330","key":"103_CR130","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1016\/j.vaccine.2008.04.071","volume":"26","author":"K Radosevic","year":"2008","unstructured":"Radosevic K, Rodriguez A, Mintardjo R, Tax D, Bengtsson KL, Thompson C, Zambon M, Weverling GJ, Uytdehaag F, Goudsmit J (2008) Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants. Vaccine 26(29\u201330):3640\u20133646. https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.071","journal-title":"Vaccine"},{"issue":"9","key":"103_CR131","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-3156.1998.00285.x","volume":"3","author":"J Richter","year":"1998","unstructured":"Richter J, Correia Dacal AR, Vergetti Siqueira JG, Poggensee G, Mannsmann U, Deelder A, Feldmeier H (1998) Sonographic prediction of variceal bleeding in patients with liver fibrosis due to Schistosoma mansoni. Trop Med Int Health 3(9):728\u2013735","journal-title":"Trop Med Int Health"},{"issue":"1","key":"103_CR132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","volume":"18","author":"S Riedel","year":"2005","unstructured":"Riedel S (2005) Edward Jenner and the history of smallpox and vaccination. Proc (Bayl Univ Med Cent) 18(1):21\u201325","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"11","key":"103_CR133","doi-asserted-by":"publisher","first-page":"e1005169","DOI":"10.1371\/journal.ppat.1005169","volume":"11","author":"JA Rodrigues","year":"2015","unstructured":"Rodrigues JA, Acosta-Serrano A, Aebi M, Ferguson MA, Routier FH, Schiller I, Soares S, Spencer D, Titz A, Wilson IB, Izquierdo L (2015) Parasite glycobiology: a Bittersweet Symphony. PLoS Pathog 11(11):e1005169. https:\/\/doi.org\/10.1371\/journal.ppat.1005169","journal-title":"PLoS Pathog"},{"issue":"4","key":"103_CR134","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nri2939","volume":"11","author":"L Romani","year":"2011","unstructured":"Romani L (2011) Immunity to fungal infections. Nat Rev Immunol 11(4):275\u2013288. https:\/\/doi.org\/10.1038\/nri2939","journal-title":"Nat Rev Immunol"},{"issue":"7545","key":"103_CR135","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney MC, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, Girard-Blanc C, Petres S, Shepard WE, Despres P, Arenzana-Seisdedos F, Dussart P, Mongkolsapaya J, Screaton GR, Rey FA (2015) Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520(7545):109\u2013113. https:\/\/doi.org\/10.1038\/nature14130","journal-title":"Nature"},{"issue":"5","key":"103_CR136","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chom.2012.04.005","volume":"11","author":"RM Roy","year":"2012","unstructured":"Roy RM, Klein BS (2012) Dendritic cells in antifungal immunity and vaccine design. Cell Host Microbe 11(5):436\u2013446. https:\/\/doi.org\/10.1016\/j.chom.2012.04.005","journal-title":"Cell Host Microbe"},{"issue":"4","key":"103_CR137","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrmicro1620","volume":"5","author":"J Royet","year":"2007","unstructured":"Royet J, Dziarski R (2007) Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences. Nat Rev Microbiol 5(4):264\u2013277. https:\/\/doi.org\/10.1038\/nrmicro1620","journal-title":"Nat Rev Microbiol"},{"issue":"20","key":"103_CR138","doi-asserted-by":"crossref","first-page":"7208","DOI":"10.1073\/pnas.84.20.7208","volume":"84","author":"CE Rubens","year":"1987","unstructured":"Rubens CE, Wessels MR, Heggen LM, Kasper DL (1987) Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A 84(20):7208\u20137212","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"103_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10409239709085144","volume":"32","author":"PM Rudd","year":"1997","unstructured":"Rudd PM, Dwek RA (1997) Glycosylation: heterogeneity and the 3D structure of proteins. Crit Rev Biochem Mol Biol 32(1):1\u2013100. https:\/\/doi.org\/10.3109\/10409239709085144","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"103_CR140","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-med-091014-090749","volume":"67","author":"S Sadanand","year":"2016","unstructured":"Sadanand S, Suscovich TJ, Alter G (2016) Broadly neutralizing antibodies against HIV: new insights to inform vaccine design. Annu Rev Med 67:185\u2013200. https:\/\/doi.org\/10.1146\/annurev-med-091014-090749","journal-title":"Annu Rev Med"},{"issue":"14","key":"103_CR141","doi-asserted-by":"crossref","first-page":"7293","DOI":"10.1128\/JVI.76.14.7293-7305.2002","volume":"76","author":"RW Sanders","year":"2002","unstructured":"Sanders RW, Venturi M, Schiffner L, Kalyanaraman R, Katinger H, Lloyd KO, Kwong PD, Moore JP (2002a) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76(14):7293\u20137305","journal-title":"J Virol"},{"issue":"17","key":"103_CR142","doi-asserted-by":"crossref","first-page":"8875","DOI":"10.1128\/JVI.76.17.8875-8889.2002","volume":"76","author":"RW Sanders","year":"2002","unstructured":"Sanders RW, Vesanen M, Schuelke N, Master A, Schiffner L, Kalyanaraman R, Paluch M, Berkhout B, Maddon PJ, Olson WC, Lu M, Moore JP (2002b) Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1. J Virol 76(17):8875\u20138889","journal-title":"J Virol"},{"key":"103_CR143","doi-asserted-by":"publisher","unstructured":"Sanders RW, Derking R, Cupo A, Julien JP, Yasmeen A, de Val N, Kim HJ, Blattner C, de la Pena AT, Korzun J, Golabek M, de Los Reyes K, Ketas TJ, van Gils MJ, King CR, Wilson IA, Ward AB, Klasse PJ, Moore JP (2013) A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies. PLoS Pathog 9(9):e1003618. https:\/\/doi.org\/10.1371\/journal.ppat.1003618","DOI":"10.1371\/journal.ppat.1003618"},{"key":"103_CR144","doi-asserted-by":"publisher","unstructured":"Sanders RW, van Gils MJ, Derking R, Sok D, Ketas TJ, Burger JA, Ozorowski G, Cupo A, Simonich C, Goo L, Arendt H, Kim HJ, Lee JH, Pugach P, Williams M, Debnath G, Moldt B, van Breemen MJ, Isik G, Medina-Ramirez M, Back JW, Koff WC, Julien JP, Rakasz EG, Seaman MS, Guttman M, Lee KK, Klasse PJ, LaBranche C, Schief WR, Wilson IA, Overbaugh J, Burton DR, Ward AB, Montefiori DC, Dean H, Moore JP (2015) HIV-1 Vaccines. HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349(6244):aac4223. https:\/\/doi.org\/10.1126\/science.aac4223","DOI":"10.1126\/science.aac4223"},{"issue":"3","key":"103_CR145","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CVI.00480-08","volume":"16","author":"SP Saville","year":"2009","unstructured":"Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL (2009) Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis. Clin Vaccine Immunol 16(3):430\u2013432. https:\/\/doi.org\/10.1128\/CVI.00480-08","journal-title":"Clin Vaccine Immunol"},{"issue":"14","key":"103_CR146","doi-asserted-by":"crossref","first-page":"7306","DOI":"10.1128\/JVI.76.14.7306-7321.2002","volume":"76","author":"CN Scanlan","year":"2002","unstructured":"Scanlan CN, Pantophlet R, Wormald MR, Ollmann Saphire E, Stanfield R, Wilson IA, Katinger H, Dwek RA, Rudd PM, Burton DR (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1\u2192\u20092 mannose residues on the outer face of gp120. J Virol 76(14):7306\u20137321","journal-title":"J Virol"},{"issue":"7139","key":"103_CR147","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nature05818","volume":"446","author":"CN Scanlan","year":"2007","unstructured":"Scanlan CN, Offer J, Zitzmann N, Dwek RA (2007) Exploiting the defensive sugars of HIV-1 for drug and vaccine design. Nature 446(7139):1038\u20131045. https:\/\/doi.org\/10.1038\/nature05818","journal-title":"Nature"},{"issue":"6","key":"103_CR148","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.cell.2015.08.035","volume":"162","author":"L Scharf","year":"2015","unstructured":"Scharf L, Wang H, Gao H, Chen S, McDowall AW, Bjorkman PJ (2015) Broadly neutralizing Antibody 8ANC195 recognizes closed and open states of HIV-1 Env. Cell 162(6):1379\u20131390. https:\/\/doi.org\/10.1016\/j.cell.2015.08.035","journal-title":"Cell"},{"issue":"7238","key":"103_CR149","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nature07930","volume":"458","author":"JF Scheid","year":"2009","unstructured":"Scheid JF, Mouquet H, Feldhahn N, Seaman MS, Velinzon K, Pietzsch J, Ott RG, Anthony RM, Zebroski H, Hurley A, Phogat A, Chakrabarti B, Li Y, Connors M, Pereyra F, Walker BD, Wardemann H, Ho D, Wyatt RT, Mascola JR, Ravetch JV, Nussenzweig MC (2009) Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 458(7238):636\u2013640. https:\/\/doi.org\/10.1038\/nature07930","journal-title":"Nature"},{"issue":"52","key":"103_CR150","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1016\/j.vaccine.2012.10.038","volume":"30","author":"CS Schmidt","year":"2012","unstructured":"Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR, Edwards JE Jr, Hennessey JP Jr (2012) NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30(52):7594\u20137600. https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.038","journal-title":"Vaccine"},{"issue":"5","key":"103_CR151","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.4049\/jimmunol.156.5.1886","volume":"156","author":"L Schofield","year":"1996","unstructured":"Schofield L, Novakovic S, Gerold P, Schwarz RT, McConville MJ, Tachado SD (1996) Glycosylphosphatidylinositol toxin of Plasmodium up-regulates intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and E-selectin expression in vascular endothelial cells and increases leukocyte and parasite cytoadherence via tyrosine kinase-dependent signal transduction. J Immunol 156(5):1886\u20131896","journal-title":"J Immunol"},{"issue":"6899","key":"103_CR152","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/nature00937","volume":"418","author":"L Schofield","year":"2002","unstructured":"Schofield L, Hewitt MC, Evans K, Siomos MA, Seeberger PH (2002) Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria. Nature 418(6899):785\u2013789. https:\/\/doi.org\/10.1038\/nature00937","journal-title":"Nature"},{"issue":"3","key":"103_CR153","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1128\/JVI.02108-09","volume":"84","author":"MS Seaman","year":"2010","unstructured":"Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, Coffey RT, Harris L, Wood B, Daniels MG, Bhattacharya T, Lapedes A, Polonis VR, McCutchan FE, Gilbert PB, Self SG, Korber BT, Montefiori DC, Mascola JR (2010) Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol 84(3):1439\u20131452. https:\/\/doi.org\/10.1128\/JVI.02108-09","journal-title":"J Virol"},{"issue":"10","key":"103_CR154","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1084\/jem.20132494","volume":"211","author":"M Shingai","year":"2014","unstructured":"Shingai M, Donau OK, Plishka RJ, Buckler-White A, Mascola JR, Nabel GJ, Nason MC, Montefiori D, Moldt B, Poignard P, Diskin R, Bjorkman PJ, Eckhaus MA, Klein F, Mouquet H, Cetrulo Lorenzi JC, Gazumyan A, Burton DR, Nussenzweig MC, Martin MA, Nishimura Y (2014) Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J Exp Med 211(10):2061\u20132074. https:\/\/doi.org\/10.1084\/jem.20132494","journal-title":"J Exp Med"},{"issue":"7","key":"103_CR155","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.4049\/jimmunol.166.7.4620","volume":"166","author":"S Shoham","year":"2001","unstructured":"Shoham S, Huang C, Chen JM, Golenbock DT, Levitz SM (2001) Toll-like receptor 4 mediates intracellular signaling without TNF-alpha release in response to Cryptococcus neoformans polysaccharide capsule. J Immunol 166(7):4620\u20134626","journal-title":"J Immunol"},{"issue":"12","key":"103_CR156","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/glycob\/cwv066","volume":"25","author":"CH Smit","year":"2015","unstructured":"Smit CH, Homann A, van Hensbergen VP, Schramm G, Haas H, van Diepen A, Hokke CH (2015) Surface expression patterns of defined glycan antigens change during Schistosoma mansoni cercarial transformation and development of schistosomula. Glycobiology 25(12):1465\u20131479. https:\/\/doi.org\/10.1093\/glycob\/cwv066","journal-title":"Glycobiology"},{"key":"103_CR157","doi-asserted-by":"publisher","unstructured":"Sok D, Doores KJ, Briney B, Le KM, Saye-Francisco KL, Ramos A, Kulp DW, Julien JP, Menis S, Wickramasinghe L, Seaman MS, Schief WR, Wilson IA, Poignard P, Burton DR (2014) Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV. Sci Transl Med 6(236):236ra263. https:\/\/doi.org\/10.1126\/scitranslmed.3008104","DOI":"10.1126\/scitranslmed.3008104"},{"issue":"11","key":"103_CR158","doi-asserted-by":"publisher","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","volume":"11","author":"R Sommerstein","year":"2015","unstructured":"Sommerstein R, Flatz L, Remy MM, Malinge P, Magistrelli G, Fischer N, Sahin M, Bergthaler A, Igonet S, Ter Meulen J, Rigo D, Meda P, Rabah N, Coutard B, Bowden TA, Lambert PH, Siegrist CA, Pinschewer DD (2015) Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection. PLoS Pathog 11(11):e1005276. https:\/\/doi.org\/10.1371\/journal.ppat.1005276","journal-title":"PLoS Pathog"},{"issue":"5","key":"103_CR159","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1086\/520536","volume":"196","author":"CA Specht","year":"2007","unstructured":"Specht CA, Nong S, Dan JM, Lee CK, Levitz SM (2007) Contribution of glycosylation to T cell responses stimulated by recombinant Cryptococcus neoformans mannoprotein. J Infect Dis 196(5):796\u2013800. https:\/\/doi.org\/10.1086\/520536","journal-title":"J Infect Dis"},{"key":"103_CR160","doi-asserted-by":"publisher","unstructured":"Spellberg B (2011) Vaccines for invasive fungal infections. F1000 Med Rep 3:13. https:\/\/doi.org\/10.3410\/m3-13","DOI":"10.3410\/m3-13"},{"issue":"7","key":"103_CR161","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1086\/529204","volume":"197","author":"B Spellberg","year":"2008","unstructured":"Spellberg B, Ibrahim AS, Lin L, Avanesian V, Fu Y, Lipke P, Otoo H, Ho T, Edwards JE Jr (2008) Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity. J Infect Dis 197(7):967\u2013971. https:\/\/doi.org\/10.1086\/529204","journal-title":"J Infect Dis"},{"key":"103_CR162","first-page":"1","volume":"6","author":"S Srinivasan","year":"2016","unstructured":"Srinivasan S, Ghosh M, Maity S, Varadarajan R (2016) Broadly neutralizing antibodies for therapy of viral infections. Antibody Technol J 6:1\u201315","journal-title":"Antibody Technol J"},{"issue":"3","key":"103_CR163","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","volume":"45","author":"JM Steichen","year":"2016","unstructured":"Steichen JM, Kulp DW, Tokatlian T, Escolano A, Dosenovic P, Stanfield RL, McCoy LE, Ozorowski G, Hu X, Kalyuzhniy O, Briney B, Schiffner T, Garces F, Freund NT, Gitlin AD, Menis S, Georgeson E, Kubitz M, Adachi Y, Jones M, Mutafyan AA, Yun DS, Mayer CT, Ward AB, Burton DR, Wilson IA, Irvine DJ, Nussenzweig MC, Schief WR (2016) HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies. Immunity 45(3):483\u2013496. https:\/\/doi.org\/10.1016\/j.immuni.2016.08.016","journal-title":"Immunity"},{"issue":"5","key":"103_CR164","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1046\/j.1365-3083.2001.00977.x","volume":"54","author":"JB Sun","year":"2001","unstructured":"Sun JB, Stadecker MJ, Mielcarek N, Lakew M, Li BL, Hernandez HJ, Czerkinsky C, Holmgren J (2001) Nasal administration of Schistosoma mansoni egg antigen-cholera B subunit conjugate suppresses hepatic granuloma formation and reduces mortality in S. mansoni-infected mice. Scand J Immunol 54(5):440\u2013447","journal-title":"Scand J Immunol"},{"issue":"5","key":"103_CR165","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.4049\/jimmunol.156.5.1897","volume":"156","author":"SD Tachado","year":"1996","unstructured":"Tachado SD, Gerold P, McConville MJ, Baldwin T, Quilici D, Schwarz RT, Schofield L (1996) Glycosylphosphatidylinositol toxin of Plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase C-dependent signaling pathway. J Immunol 156(5):1897\u20131907","journal-title":"J Immunol"},{"issue":"10","key":"103_CR166","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1086\/420740","volume":"38","author":"EM Tedaldi","year":"2004","unstructured":"Tedaldi EM, Baker RK, Moorman AC, Wood KC, Fuhrer J, McCabe RE, Holmberg SD, Investigators HIVOS (2004) Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis 38(10):1478\u20131484. https:\/\/doi.org\/10.1086\/420740","journal-title":"Clin Infect Dis"},{"issue":"Pt 7","key":"103_CR167","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1099\/jmm.0.039438-0","volume":"61","author":"VS Terra","year":"2012","unstructured":"Terra VS, Mills DC, Yates LE, Abouelhadid S, Cuccui J, Wren BW (2012) Recent developments in bacterial protein glycan coupling technology and glycoconjugate vaccine design. J Med Microbiol 61(Pt 7):919\u2013926. https:\/\/doi.org\/10.1099\/jmm.0.039438-0","journal-title":"J Med Microbiol"},{"issue":"1","key":"103_CR168","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1462-5822.2003.00337.x","volume":"6","author":"PG Thomas","year":"2004","unstructured":"Thomas PG, Harn DA Jr (2004) Immune biasing by helminth glycans. Cell Microbiol 6(1):13\u201322","journal-title":"Cell Microbiol"},{"issue":"7","key":"103_CR169","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrmicro1712","volume":"5","author":"SM Todryk","year":"2007","unstructured":"Todryk SM, Hill AV (2007) Malaria vaccines: the stage we are at. Nat Rev Microbiol 5(7):487\u2013489. https:\/\/doi.org\/10.1038\/nrmicro1712","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"103_CR170","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20050749","volume":"202","author":"A Torosantucci","year":"2005","unstructured":"Torosantucci A, Bromuro C, Chiani P, De Bernardis F, Berti F, Galli C, Norelli F, Bellucci C, Polonelli L, Costantino P, Rappuoli R, Cassone A (2005) A novel glyco-conjugate vaccine against fungal pathogens. J Exp Med 202(5):597\u2013606. https:\/\/doi.org\/10.1084\/jem.20050749","journal-title":"J Exp Med"},{"key":"103_CR171","unstructured":"US Food and Drug Administration (2015) Complete list of vaccines licensed for immunization and distribution in the US. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm093833.htm"},{"issue":"1","key":"103_CR172","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02388078","volume":"58","author":"JE van Dam","year":"1990","unstructured":"van Dam JE, Fleer A, Snippe H (1990) Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides. Antonie Van Leeuwenhoek 58(1):1\u201347","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"4","key":"103_CR173","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1021\/acs.bioconjchem.5b00617","volume":"27","author":"RM van der Put","year":"2016","unstructured":"van der Put RM, Kim TH, Guerreiro C, Thouron F, Hoogerhout P, Sansonetti PJ, Westdijk J, Stork M, Phalipon A, Mulard LA (2016) A synthetic carbohydrate conjugate vaccine candidate against shigellosis: improved bioconjugation and impact of alum on immunogenicity. Bioconjug Chem 27(4):883\u2013892. https:\/\/doi.org\/10.1021\/acs.bioconjchem.5b00617","journal-title":"Bioconjug Chem"},{"issue":"11","key":"103_CR174","doi-asserted-by":"publisher","first-page":"e1922","DOI":"10.1371\/journal.pntd.0001922","volume":"6","author":"A van Diepen","year":"2012","unstructured":"van Diepen A, Smit CH, van Egmond L, Kabatereine NB, Pinot de Moira A, Dunne DW, Hokke CH (2012a) Differential anti-glycan antibody responses in Schistosoma mansoni-infected children and adults studied by shotgun glycan microarray. PLoS Negl Trop Dis 6(11):e1922. https:\/\/doi.org\/10.1371\/journal.pntd.0001922","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"103_CR175","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1017\/S0031182012000273","volume":"139","author":"A van Diepen","year":"2012","unstructured":"van Diepen A, Van der Velden NS, Smit CH, Meevissen MH, Hokke CH (2012b) Parasite glycans and antibody-mediated immune responses in Schistosoma infection. Parasitology 139(9):1219\u20131230. https:\/\/doi.org\/10.1017\/S0031182012000273","journal-title":"Parasitology"},{"issue":"7","key":"103_CR176","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ijpara.2015.02.008","volume":"45","author":"A van Diepen","year":"2015","unstructured":"van Diepen A, van der Plas AJ, Kozak RP, Royle L, Dunne DW, Hokke CH (2015) Development of a Schistosoma mansoni shotgun O-glycan microarray and application to the discovery of new antigenic schistosome glycan motifs. Int J Parasitol 45(7):465\u2013475. https:\/\/doi.org\/10.1016\/j.ijpara.2015.02.008","journal-title":"Int J Parasitol"},{"issue":"13","key":"103_CR177","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.micinf.2004.06.004","volume":"6","author":"AM Van Roon","year":"2004","unstructured":"Van Roon AM, Van de Vijver KK, Jacobs W, Van Marck EA, Van Dam GJ, Hokke CH, Deelder AM (2004) Discrimination between the anti-monomeric and the anti-multimeric Lewis X response in murine schistosomiasis. Microbes Infect 6(13):1125\u20131132. https:\/\/doi.org\/10.1016\/j.micinf.2004.06.004","journal-title":"Microbes Infect"},{"issue":"6","key":"103_CR178","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/mmy.38.6.407.417","volume":"38","author":"A Vecchiarelli","year":"2000","unstructured":"Vecchiarelli A (2000) Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 38(6):407\u2013417","journal-title":"Med Mycol"},{"issue":"5","key":"103_CR179","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tim.2007.03.003","volume":"15","author":"DJ Vigerust","year":"2007","unstructured":"Vigerust DJ, Shepherd VL (2007) Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 15(5):211\u2013218. https:\/\/doi.org\/10.1016\/j.tim.2007.03.003","journal-title":"Trends Microbiol"},{"issue":"18","key":"103_CR180","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.1073\/pnas.0509207103","volume":"103","author":"M Wacker","year":"2006","unstructured":"Wacker M, Feldman MF, Callewaert N, Kowarik M, Clarke BR, Pohl NL, Hernandez M, Vines ED, Valvano MA, Whitfield C, Aebi M (2006) Substrate specificity of bacterial oligosaccharyltransferase suggests a common transfer mechanism for the bacterial and eukaryotic systems. Proc Natl Acad Sci U S A 103(18):7088\u20137093. https:\/\/doi.org\/10.1073\/pnas.0509207103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7365","key":"103_CR181","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature10373","volume":"477","author":"LM Walker","year":"2011","unstructured":"Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP, Wang SK, Ramos A, Chan-Hui PY, Moyle M, Mitcham JL, Hammond PW, Olsen OA, Phung P, Fling S, Wong CH, Phogat S, Wrin T, Simek MD, Protocol GPI, Koff WC, Wilson IA, Burton DR, Poignard P (2011) Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 477(7365):466\u2013470. https:\/\/doi.org\/10.1038\/nature10373","journal-title":"Nature"},{"issue":"6","key":"103_CR182","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.cbpa.2013.10.001","volume":"17","author":"LX Wang","year":"2013","unstructured":"Wang LX (2013) Synthetic carbohydrate antigens for HIV vaccine design. Curr Opin Chem Biol 17(6):997\u20131005","journal-title":"Curr Opin Chem Biol"},{"issue":"2","key":"103_CR183","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.micinf.2006.11.006","volume":"9","author":"A Warburg","year":"2007","unstructured":"Warburg A, Shtern A, Cohen N, Dahan N (2007) Laminin and a Plasmodium ookinete surface protein inhibit melanotic encapsulation of Sephadex beads in the hemocoel of mosquitoes. Microbes Infect 9(2):192\u2013199. https:\/\/doi.org\/10.1016\/j.micinf.2006.11.006","journal-title":"Microbes Infect"},{"key":"103_CR184","unstructured":"WHO (2015) Immunization, vaccines and biologicals\u2014WHO recommendations for routine immunization\u2014summary tables"},{"issue":"5","key":"103_CR185","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/infdis\/126.5.514","volume":"126","author":"FA Wyle","year":"1972","unstructured":"Wyle FA, Artenstein MS, Brandt BL, Tramont EC, Kasper DL, Altieri PL, Berman SL, Lowenthal JP (1972) Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 126(5):514\u2013521","journal-title":"J Infect Dis"},{"issue":"36","key":"103_CR186","doi-asserted-by":"publisher","first-page":"13526","DOI":"10.1073\/pnas.0803195105","volume":"105","author":"H Xin","year":"2008","unstructured":"Xin H, Dziadek S, Bundle DR, Cutler JE (2008) Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci U S A 105(36):13526\u201313531. https:\/\/doi.org\/10.1073\/pnas.0803195105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"103_CR187","doi-asserted-by":"publisher","first-page":"e0126428","DOI":"10.1371\/journal.pone.0126428","volume":"10","author":"Z Yang","year":"2015","unstructured":"Yang Z, Li J, Liu Q, Yuan T, Zhang Y, Chen LQ, Lou Q, Sun Z, Ying H, Xu J, Dimitrov DS, Zhang MY (2015) Identification of non-HIV immunogens that bind to Germline b12 predecessors and prime for elicitation of cross-clade neutralizing HIV-1 antibodies. PLoS ONE 10(5):e0126428. https:\/\/doi.org\/10.1371\/journal.pone.0126428","journal-title":"PLoS ONE"},{"issue":"6","key":"103_CR188","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.cell.2014.10.053","volume":"159","author":"B Yilmaz","year":"2014","unstructured":"Yilmaz B, Portugal S, Tran TM, Gozzelino R, Ramos S, Gomes J, Regalado A, Cowan PJ, d\u2019Apice AJ, Chong AS, Doumbo OK, Traore B, Crompton PD, Silveira H, Soares MP (2014) Gut microbiota elicits a protective immune response against malaria transmission. Cell 159(6):1277\u20131289. https:\/\/doi.org\/10.1016\/j.cell.2014.10.053","journal-title":"Cell"},{"issue":"3","key":"103_CR189","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"L Zhao","year":"2014","unstructured":"Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu C, Middelberg AP (2014) Nanoparticle vaccines. Vaccine 32(3):327\u2013337. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.069","journal-title":"Vaccine"},{"issue":"8","key":"103_CR190","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1128\/IAI.70.8.4083-4091.2002","volume":"70","author":"J Zhou","year":"2002","unstructured":"Zhou J, Lottenbach KR, Barenkamp SJ, Lucas AH, Reason DC (2002) Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F. Infect Immun 70(8):4083\u20134091","journal-title":"Infect Immun"}],"container-title":["Current Topics in Microbiology and Immunology","Vaccination Strategies Against Highly Variable Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2018_103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T23:18:02Z","timestamp":1693783082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/82_2018_103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783030580032","9783030580049"],"references-count":190,"URL":"https:\/\/doi.org\/10.1007\/82_2018_103","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"26 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}